Information Journal Paper
APA:
Copy. (2019). Oral esketamine for treatmentresistant depression: rationale and design of a randomized controlled trial. BMC PSYCHIATRY, 19(1), 0-0. SID. https://sid.ir/paper/771490/en
Vancouver:
Copy. Oral esketamine for treatmentresistant depression: rationale and design of a randomized controlled trial. BMC PSYCHIATRY[Internet]. 2019;19(1):0-0. Available from: https://sid.ir/paper/771490/en
IEEE:
Copy, “Oral esketamine for treatmentresistant depression: rationale and design of a randomized controlled trial,” BMC PSYCHIATRY, vol. 19, no. 1, pp. 0–0, 2019, [Online]. Available: https://sid.ir/paper/771490/en